Related Experiment Video
Updated: Sep 30, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Clinical implications of statin event trials
1Lipid Research Center, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8046, St. Louis, MO 63110, USA. agoldber@im.wustl.edu
Insights
Statin therapy significantly reduces cardiovascular events like heart attacks and strokes. Long-term studies show similar effectiveness and safety profiles for commonly used statins, with ongoing research to determine optimal cholesterol reduction levels.
Area of Science:
- Cardiovascular medicine
- Pharmacology
Background:
- Statin therapy is widely used for cardiovascular disease prevention.
- Previous trials demonstrated the efficacy of statins in reducing cardiovascular events.
Purpose of the Study:
- To review the effects of statin therapy on cardiovascular events.
- To compare the safety and efficacy of different statins.
Main Methods:
- Review of long-term clinical trials involving statin therapy.
- Analysis of data on myocardial infarction, stroke, revascularizations, and mortality.
Main Results:
- Statin therapy shows a beneficial effect on cardiovascular event rates.
- Lovastatin, pravastatin, and simvastatin demonstrated similar effects on key cardiovascular outcomes and comparable safety profiles.
- Ongoing trials are investigating other statins and optimal low-density lipoprotein cholesterol targets.
Conclusions:
- Statin therapy is effective in reducing cardiovascular events.
- Current evidence suggests comparable efficacy and safety among commonly used statins.
- Further research is needed to establish optimal lipid-lowering goals.
Abstract:
Event trials using statin therapy have shown a beneficial effect on rates of cardiovascular events. The three statins that have been used in long-term trials have shown generally similar effects on rates of myocardial infarction, stroke, revascularizations, and mortality. Safety data appear to be comparable for lovastatin, pravastatin, and simvastatin. Long-term trials of other statins are in progress or pending. The question of how much low-density lipoprotein cholesterol should be lowered may be answered by studies currently in progress.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Clinical Trials: Overview